These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7835800)

  • 1. Characteristics relating to ovarian cancer risk: implications for prevention and detection.
    Whittemore AS
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S15-9. PubMed ID: 7835800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis.
    Modugno F; Ness RB; Allen GO; Schildkraut JM; Davis FG; Goodman MT
    Am J Obstet Gynecol; 2004 Sep; 191(3):733-40. PubMed ID: 15467532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology and screening of ovarian cancer.
    Tortolero-Luna G; Mitchell MF; Rhodes-Morris HE
    Obstet Gynecol Clin North Am; 1994 Mar; 21(1):1-23. PubMed ID: 8015758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
    Satagopan JM; Boyd J; Kauff ND; Robson M; Scheuer L; Narod S; Offit K
    Clin Cancer Res; 2002 Dec; 8(12):3776-81. PubMed ID: 12473589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Researchers can now investigate long-term effects of OCs on cancer.
    Rubin GL; Peterson HB
    Contracept Technol Update; 1985 Jan; 6(1):7-12. PubMed ID: 12279918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of reproductive factors and oral contraceptives on breast cancer risk in BRCA1/2 mutation carriers and noncarriers: results from a population-based study.
    Lee E; Ma H; McKean-Cowdin R; Van Den Berg D; Bernstein L; Henderson BE; Ursin G
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3170-8. PubMed ID: 18990759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risks of oral contraceptive use in women over 35.
    Stenchever MA
    J Reprod Med; 1993 Dec; 38(12 Suppl):1030-5. PubMed ID: 8120860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for ovarian cancer in central Italy.
    Greggi S; Parazzini F; Paratore MP; Chatenoud L; Legge F; Mancuso S; La Vecchia C
    Gynecol Oncol; 2000 Oct; 79(1):50-4. PubMed ID: 11006030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A survey of preventive measures among BRCA1 mutation carriers from Poland.
    Gronwald J; Byrski T; Huzarski T; Cybulski C; Stawicka M; Szwiec M; Debniak T; Tulman A; Sun P; Oszurek O; Lubinski J; Narod SA
    Clin Genet; 2007 Feb; 71(2):153-7. PubMed ID: 17250664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reproductive factors of ovarian and endometrial cancer risk in a high fertility population in Mexico.
    Salazar-Martinez E; Lazcano-Ponce EC; Gonzalez Lira-Lira G; Escudero-De los Rios P; Salmeron-Castro J; Hernandez-Avila M
    Cancer Res; 1999 Aug; 59(15):3658-62. PubMed ID: 10446978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should women with familial ovarian cancer undergo prophylactic oophorectomy?
    Kerlikowske K; Brown JS; Grady DG
    Obstet Gynecol; 1992 Oct; 80(4):700-7. PubMed ID: 1407898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral contraceptives and ovarian cancer: an update, 1998-2004.
    La Vecchia C
    Eur J Cancer Prev; 2006 Apr; 15(2):117-24. PubMed ID: 16523008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Women's awareness of ovarian cancer risks and symptoms.
    Lockwood-Rayermann S; Donovan HS; Rambo D; Kuo CW
    Am J Nurs; 2009 Sep; 109(9):36-45; quiz 46. PubMed ID: 19704232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral contraceptive pills. Prevention of ovarian cancer and other benefits.
    Berchuck A; Schildkraut J
    N C Med J; 1997; 58(6):404-7; discussion 408. PubMed ID: 9392951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The estimated effect of oral contraceptive use on the cumulative risk of epithelial ovarian cancer.
    Gross TP; Schlesselman JJ
    Obstet Gynecol; 1994 Mar; 83(3):419-24. PubMed ID: 8127536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention with tamoxifen or other hormones versus prophylactic surgery in BRCA1/2-positive women: a decision analysis.
    Grann VR; Jacobson JS; Whang W; Hershman D; Heitjan DF; Antman KH; Neugut AI
    Cancer J Sci Am; 2000; 6(1):13-20. PubMed ID: 10696733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and risk assessment for ovarian cancer.
    Daly M; Obrams GI
    Semin Oncol; 1998 Jun; 25(3):255-64. PubMed ID: 9633839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian and endometrial cancers.
    Mant JW; Vessey MP
    Cancer Surv; 1994; 19-20():287-307. PubMed ID: 7895220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of oral contraceptive use, other contraceptive methods, and infertility with ovarian cancer risk.
    Tworoger SS; Fairfield KM; Colditz GA; Rosner BA; Hankinson SE
    Am J Epidemiol; 2007 Oct; 166(8):894-901. PubMed ID: 17656616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.